Page last updated: 2024-11-05

trimebutine and Cerebrovascular Disorders

trimebutine has been researched along with Cerebrovascular Disorders in 1 studies

Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.

Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inoue, K1
Kobatake, K1
Haruma, K1
Yamanaka, H1
Fujimura, J1
Yoshihara, M1
Sumii, K1
Kajiyama, G1

Other Studies

1 other study available for trimebutine and Cerebrovascular Disorders

ArticleYear
[Gastric emptying in elderly patients with cerebral vascular diseases and the effect of trimebutine].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1993, Volume: 30, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Female; Gastric Emptying; Humans; Male; P

1993